Frequently Asked Questions logo
Frequently Asked Questions logo

All articles

Why are the ranges different for the blood spot lab tests? Are they comparable to my previous test?Updated 18 days ago

When transitioning from EIA (Enzyme Immunoassay) to ECLIA (Electrochemiluminescence Immunoassay) methodology, the ranges for certain biomarkers may shift slightly due to differences in the testing technology. ECLIA offers enhanced precision, sensitivity, and reliability in detecting biomarker levels. This improvement can result in more refined and accurate ranges that better reflect optimal functional health targets.

These adjustments ensure that the data provided aligns with the most advanced and reliable standards in lab testing. While the methodology has evolved, rest assured that the intent remains the same: to provide actionable insights to support your health journey.

While both EIA (Enzyme Immunoassay) and ECLIA (Electrochemiluminescence Immunoassay) methodologies are designed to measure biomarkers effectively, the results may not be directly comparable due to differences in testing sensitivity and precision.

ECLIA technology is more advanced, offering enhanced accuracy and consistency in detecting biomarker levels. As a result, the ranges and results obtained using ECLIA may differ slightly from those measured with EIA. This does not mean that previous EIA results are invalid—they remain accurate and actionable based on the methodology used at the time. However, ECLIA provides a more refined measurement, which is why it has been adopted to further improve the quality of your testing.

If you're tracking your health over time, it's essential to note the testing methodology used, as slight variations may occur due to these advancements in technology.


Was this article helpful?
Yes
No